Condition
Recurrent Castration-Sensitive Prostate Carcinoma
ClinicalTrials.gov condition label
Clinical trials
1 shownCommon interventions
AbirateroneDRUG1ApalutamideDRUG1Biospecimen CollectionPROCEDURE1Bone ScanPROCEDURE1Computed TomographyPROCEDURE1DarolutamideDRUG1DegarelixDRUG1EnzalutamideDRUG1GoserelinDRUG1HistrelinDRUG1Image-Guided TherapyPROCEDURE1LeuprolideDRUG1Magnetic Resonance ImagingPROCEDURE1Patient ObservationOTHER1Positron Emission TomographyPROCEDURE1PrednisoneDRUG1Questionnaire AdministrationOTHER1Radiation TherapyRADIATION1RelugolixDRUG1Stereotactic Body Radiation TherapyRADIATION1TriptorelinDRUG1
Leading sponsors
Trial status mix
RECRUITING1
Phase mix
PHASE21
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.